By How Much and How Quickly Does Reduction in Serum Cholesterol Concentration Lower Risk of Ischaemic Heart Disease?

Overview

Journal BMJ

Specialty General Medicine

Date 1994 Feb 5

PMID 8043072

Citations 247

Authors

M R Law

N J Wald

S G Thompson

Affiliations

Soon will be listed here.

Abstract

Objective: To estimate by how much and how quickly a given reduction in serum cholesterol concentration will reduce the risk of ischaemic heart disease.

Design: Data on the incidence of ischaemic heart disease and serum cholesterol concentration were analysed from 10 prospective (cohort) studies, three international studies in different communities, and 28 randomised controlled trials (with mortality data analysed according to allocated treatment to ensure the avoidance of bias).

Main Outcome Measure: Decrease in incidence of ischaemic heart disease or mortality for a 0.6 mmol/l (about 10%) decrease in serum cholesterol concentration.

Results: For men results from the cohort studies showed that a decrease of serum cholesterol concentration of 0.6 mmol/l (about 10%) was associated with a decrease in incidence of ischaemic heart disease of 54% at age 40 years, 39% at age 50, 27% at 60, 20% at 70, and 19% at 80. The combined estimate from the three international studies (for ages 55-64 years) was 38% (95% confidence interval 33% to 42%), somewhat greater than the cohort study estimate of 27%. The reductions in incidence of ischaemic heart disease in the randomised trials (for ages 55-64 years) were 7% (0 to 14%) in the first two years, 22% (15% to 28%) from 2.1-5 years, and 25% (15% to 35%) after five years, the last estimate being close to the estimate of 27% for the long term reduction from the cohort studies. The data for women are limited but indicate a similar effect.

Conclusions: The results from the cohort studies, international comparisons, and clinical trials are remarkably consistent. The cohort studies, based on half a million men and 18,000 ischaemic heart disease events, estimate that a long term reduction in serum cholesterol concentration of 0.6 mmol/l (10%), which can be achieved by moderate dietary change, lowers the risk of ischaemic heart disease by 50% at age 40, falling to 20% at age 70. The randomised trials, based on 45,000 men and 4000 ischaemic heart disease events show that the full effect of the reduction in risk is achieved by five years.

Citing Articles

The Gut-Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction.

Rivera K, Gonzalez L, Bravo L, Manjarres L, Andia M Int J Mol Sci. 2024; 25(22).

PMID: 39596530 PMC: 11595032. DOI: 10.3390/ijms252212465.

FBXO28 reduces high-fat diet-induced hyperlipidemia in mice by alleviating abnormal lipid metabolism and inflammatory responses.

Sun J, DU B, Chen M, Jia J, Wang X, Hong J J Endocrinol Invest. 2024; 47(11):2757-2774.

PMID: 38696123 DOI: 10.1007/s40618-024-02376-5.

High-intensity interval training is not superior to continuous aerobic training in reducing body fat: A systematic review and meta-analysis of randomized clinical trials.

Kramer A, Martins J, de Oliveira P, Lehnen A, Waclawovsky G J Exerc Sci Fit. 2023; 21(4):385-394.

PMID: 37927356 PMC: 10624584. DOI: 10.1016/j.jesf.2023.09.002.

Effects of diets containing fish oils or fish oil concentrates with high cetoleic acid content on the circulating cholesterol concentration in rodents. A systematic review and meta-analysis.

Mjaatveit M, Oldernes H, Gudbrandsen O Br J Nutr. 2023; 131(4):606-621.

PMID: 37737066 PMC: 10803824. DOI: 10.1017/S0007114523002118.

Analysis of the effect of glutamyltransferase on hyperlipidemia based on decision tree.

Zhang T, Ouyang D, Sun C, Bi Y, He L, Bai H Digit Health. 2023; 9:20552076231185441.

PMID: 37426583 PMC: 10328008. DOI: 10.1177/20552076231185441.

References

MARMORSTON J, MOORE F, HOPKINS C, KUZMA O, Weiner J . Clinical studies of long-term estrogen therapy in men with mvocardial infarction. Proc Soc Exp Biol Med. 1962; 110:400-8. DOI: 10.3181/00379727-110-27531. View

STEMMERMANN G, Chyou P, Kagan A, Nomura A, Yano K . Serum cholesterol and mortality among Japanese-American men. The Honolulu (Hawaii) Heart Program. Arch Intern Med. 1991; 151(5):969-72. View

Neaton J, Wentworth D . Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992; 152(1):56-64. View

BRADFORD R, SHEAR C, CHREMOS A, Dujovne C, Downton M, FRANKLIN F . Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med. 1991; 151(1):43-9. DOI: 10.1001/archinte.151.1.43. View

Brown G, Albers J, Fisher L, Schaefer S, Lin J, Kaplan C . Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990; 323(19):1289-98. DOI: 10.1056/NEJM199011083231901. View

Buchwald H, VARCO R, Matts J, Long J, Fitch L, Campbell G . Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990; 323(14):946-55. DOI: 10.1056/NEJM199010043231404. View

Goldbourt U, Yaari S . Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel. Arteriosclerosis. 1990; 10(4):512-9. DOI: 10.1161/01.atv.10.4.512. View

Tornberg S, Holm L, Carstensen J, Eklund G . Cancer incidence and cancer mortality in relation to serum cholesterol. J Natl Cancer Inst. 1989; 81(24):1917-21. DOI: 10.1093/jnci/81.24.1917. View

Burr M, Fehily A, Gilbert J, Rogers S, Holliday R, Sweetnam P . Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989; 2(8666):757-61. DOI: 10.1016/s0140-6736(89)90828-3. View

10.

Livesley B . Running out of staff for the NHS. BMJ. 1989; 299(6690):1-2. PMC: 1837007. DOI: 10.1136/bmj.299.6690.1. View

11.

Leren P . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand Suppl. 1966; 466:1-92. View

12.

BEGG T, Rifkind B . [Evaluation of clofibrate therapy in peripheral arteriopathy]. Minerva Med. 1971; 62(72):3469-75. View

13.

Gross L, Figueredo R . Long-term cholesterol-lowering effect of colestipol resin in humans. J Am Geriatr Soc. 1973; 21(12):552-6. DOI: 10.1111/j.1532-5415.1973.tb01662.x. View

14.

Detre K, Shaw L . Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study. Circulation. 1974; 50(5):998-1005. DOI: 10.1161/01.cir.50.5.998. View

15.

Robertson T, Kato H, Rhoads G, Kagan A, Marmot M, Syme S . Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol. 1977; 39(2):239-43. DOI: 10.1016/s0002-9149(77)80197-5. View

16.

Dorr A, Gundersen K, Schneider Jr J, Spencer T, Martin W . Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. J Chronic Dis. 1978; 31(1):5-14. DOI: 10.1016/0021-9681(78)90076-0. View

17.

WOODHILL J, Palmer A, Leelarthaepin B, McGilchrist C, BLACKET R . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Adv Exp Med Biol. 1978; 109:317-30. DOI: 10.1007/978-1-4684-0967-3_18. View

18.

Rosenhamer G, Carlson L . Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. Atherosclerosis. 1980; 37(1):129-42. DOI: 10.1016/0021-9150(80)90100-8. View

19.

McCaughan D . The long-term effects of probucol on serum lipid levels. Arch Intern Med. 1981; 141(11):1428-32. View

20.

Lewis B, Hammett F, Katan M, Kay R, Merkx I, Nobels A . Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet. 1981; 2(8259):1310-3. DOI: 10.1016/s0140-6736(81)91339-8. View